Chronic myeloid leukemia after treatment with 131I for thyroid carcinoma

Journal of the Chinese Medical Association

Volumn 68, Issue 5, 2005, Pages 230-233

  Wang, Kang Ling ^a   Lin, Liang Yu ^b   Chen, Po Min ^b,c   Lin, Hong Da ^b,c  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chronic myeloid leukemia; Radioiodine therapy; Thyroid cancer

Indexed keywords

IODINE 131;

ACUTE LEUKEMIA; ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; DRUG DOSE REGIMEN; HUMAN; LEUKEMOGENESIS; LYMPH NODE DISSECTION; MALE; MEDICAL LITERATURE; NECK; PHILADELPHIA 1 CHROMOSOME; THYROID CARCINOMA; THYROIDECTOMY;

EID: 18744376027     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70213-8     Document Type: Article

References (19)

1. Pochin EE. Leukaemia following radioiodine treatment of thyrotoxicosis. Br Med J 1960;2:1545-50.
2. Pochin EE. Prospects from the treatment of thyroid carcinoma with radioiodine. Clin Radiol 1967;18:113-5.
3. Saenger EL, Thoma GE, Tompkins EA. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study. JAMA 1968;205:855-62.
4. Brincker H, Hansen HS, Anderson AP. Induction of leukaemia by 131-I treatment of thyroid carcinoma. Br J Cancer 1973; 28:232-7.
5. Edmonds CJ, Smith T. The long-term hazards of treatment of thyroid cancer with radioiodine. Br J Radiol 1986;59:45-51.
6. 131I therapy for thyroid carcinoma. J Nucl Med 1963; 4:85-91.
7. Van Nostrand D, Neutze J, Atkins F. Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. J Nucl Med 1986;27:1519-27.
8. Ozarda A, Ergin U, Bender MA. Chronic myelogenous leukemia following I-131 therapy for metastatic thyroid carcinoma. Report of a case and some considerations on the etiologic factors. Am J Roentgenol Radium Ther Nucl Med 1961;85: 914-8.
9. Bundi RS, Scott JS, Halnan KE. Chronic myeloid leukaemia following radioiodine therapy for carcinoma thyroid. Br J Radiol 1977;50:61-4.
10. 131I therapy for metastatic thyroid carcinoma. J Formos Med Assoc 1984;83:730-5.
11. Walgraeve D, Verhoef G, Stul M, Cassiman JJ, Mecucci C, Van den Berghe H, Boogaerts M. Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma. Report of a case and review of the literature. Cancer Genet Cytogenet 1991; 55:217-24.
12. Advani SH, Hege UP. Leukemia after 131I treatment of thyroid cancer - comments on the article 'Second cancer following chemotherapy and radiotherapy - and epidemiological perspective' by J. Kaldor. Acta Oncol 1992; 31:65.
13. 131I treatment for thyroid carcinoma: a report of two cases and review of the literature. Clin Endocrinol 1995;43: 651-4.
14. Alfiar F, Amato D, Lipton JH. Chronic myeloid leukemia in a woman with papillary carcinoma of the thyroid treated with radioactive iodine. Leuk Lymphoma 1997;27:365-7.
15. Molony WC. Radiogenic leukemia revisited. Blood 1987;70: 905-8.
16. Ivanov VK, Tsyb AF, Nilova EV, Efendiev VF, Gorsky AI, Pitkevich VA, Leshakov SY, et al. Cancer risks in the Kaluga oblast of the Russian Federation 10 years after the Chernobyl accident. Radiat Environ Biophys 1997;36:161-7.
17. Hall P, Boice JD, Berg G, Bjelkengren G, Ericsson UB, Hallquist A, Lidberg M, et al. Leukaemia incidence after iodine-131 exposure. Lancet 1992;340:1-4.
18. Dortorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 1995;36:21-7.
19. Vatharie F, Schlumberger M, Delisle MJ, Francese C, Challenton C, Genardiere E, Meunier F, et al. Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 1997;75:734-9.